标题
mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology
作者
关键词
mTOR, Rapamycin, Sirolimus, Everolimus, Tuberous sclerosis
出版物
Current Neurology and Neuroscience Reports
Volume 16, Issue 12, Pages -
出版商
Springer Nature
发表日期
2016-11-04
DOI
10.1007/s11910-016-0708-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
- (2016) Jacqueline A French et al. LANCET
- Symptom profiles of autism spectrum disorder in tuberous sclerosis complex
- (2016) Shafali S. Jeste et al. NEUROLOGY
- Familial focal epilepsy with focal cortical dysplasia due toDEPDC5mutations
- (2015) Stéphanie Baulac et al. ANNALS OF NEUROLOGY
- Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex
- (2015) Nicholas Rensing et al. EPILEPSIA
- Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy
- (2015) Jae Seok Lim et al. NATURE MEDICINE
- Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
- (2015) Christina Gross et al. Neurotherapeutics
- Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers
- (2015) Aglaia Vignoli et al. Orphanet Journal of Rare Diseases
- Developmental brain abnormalities in tuberous sclerosis complex: A comparative tissue analysis of cortical tubers and perituberal cortex
- (2014) Véronique Ruppe et al. EPILEPSIA
- Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
- (2014) David Neal Franz et al. LANCET ONCOLOGY
- The Neurology of mTOR
- (2014) Jonathan O. Lipton et al. NEURON
- Atypical focal cortical dysplasia in a patient with Cowden syndrome
- (2014) KM Cheung et al. HONG KONG MEDICAL JOURNAL
- Everolimus treatment of refractory epilepsy in tuberous sclerosis complex
- (2013) Darcy A. Krueger et al. ANNALS OF NEUROLOGY
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Mutations of DEPDC5 cause autosomal dominant focal epilepsies
- (2013) Saeko Ishida et al. NATURE GENETICS
- Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012
- (2013) Jonathan Roth et al. PEDIATRIC NEUROLOGY
- Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Darcy A. Krueger et al. PEDIATRIC NEUROLOGY
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Hope Northrup et al. PEDIATRIC NEUROLOGY
- Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex
- (2013) Mary Kay Koenig et al. Drugs in research & development
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome
- (2012) C. A. Hoeffer et al. GENES BRAIN AND BEHAVIOR
- Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex
- (2012) Tracy S. Ma et al. Journal of Neurosurgery-Pediatrics
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
- (2012) Jeong Ho Lee et al. NATURE GENETICS
- Somatic Activation of AKT3 Causes Hemispheric Developmental Brain Malformations
- (2012) Annapurna Poduri et al. NEURON
- Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
- (2012) Atsushi Sato et al. Nature Communications
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
- (2011) Jennifer C. Darnell et al. CELL
- Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex
- (2011) A. L. Numis et al. NEUROLOGY
- Topical Rapamycin
- (2010) Anna K. Haemel et al. ARCHIVES OF DERMATOLOGY
- STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
- (2010) Ksenia A. Orlova et al. JOURNAL OF CLINICAL INVESTIGATION
- Dysregulation of mTOR Signaling in Fragile X Syndrome
- (2010) A. Sharma et al. JOURNAL OF NEUROSCIENCE
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders
- (2010) Dan Ehninger et al. TRENDS IN MOLECULAR MEDICINE
- Autism spectrum disorder in fragile X syndrome: A longitudinal evaluation
- (2009) R. Nick Hernandez et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- The natural history of epilepsy in tuberous sclerosis complex
- (2009) Catherine J. Chu-Shore et al. EPILEPSIA
- Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature
- (2009) M. E. A. P. M. Adriaensen et al. EUROPEAN JOURNAL OF NEUROLOGY
- mTOR signaling: At the crossroads of plasticity, memory and disease
- (2009) Charles A. Hoeffer et al. TRENDS IN NEUROSCIENCES
- Origins of Epilepsy in Fragile X Syndrome
- (2009) Paul J. Hagerman et al. Epilepsy Currents
- Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
- (2008) Ling-Hui Zeng et al. ANNALS OF NEUROLOGY
- The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
- (2008) G.F.L. Hofbauer et al. BRITISH JOURNAL OF DERMATOLOGY
- Regression of Subependymal Giant Cell Astrocytoma With Rapamycin in Tuberous Sclerosis Complex
- (2008) Mary Kay Koenig et al. JOURNAL OF CHILD NEUROLOGY
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
- (2008) Andrea Williams et al. Nature Chemical Biology
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search